Anchordx
China · Founded 2015 · $73.0M raised
- Founded
- 2015
- Business Model
- B2B
- Website
- anchordx.com
- Total Funding
- $73.0M
- Last Round
- $28.0M Extension RoundFeb 2021
- Rounds
- 4
About
Pioneer applying ctDNA methylation sequencing technology for early tumor detection in China.
Summary
Anchordx is a Biotech company based in China, founded in 2015. It has raised $73.0M in total across 4 rounds, most recently a $28.0M Extension Round round in Feb 2021. Investors include Marathon Venture Partners, 6 Dimensions Capital and Northern Light Ventures.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Feb 2021
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...